Tomoki Nakamura

Tsu, 5148507, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 152 publications

Is the CALLY Index the Best Tool for Predicting Survival in Patients with Primary Soft Tissue Sarcomas?

Is the CALLY Index the Best Tool for Predicting Survival in Patients with Primary Soft Tissue Sarcomas?

Journal: Diagnostics (Basel, Switzerland)

Published: July 17, 2026

Clinical Diagnosis and Treatment in Patients with Schwannoma at a Single Institute.

Clinical Diagnosis and Treatment in Patients with Schwannoma at a Single Institute.

Journal: Diagnostics (Basel, Switzerland)

Published: June 12, 2026

Radiodynamic Therapy Using Local Administration of 5-Aminolevulinic Acid for In Vivo Osteosarcoma Xenograft Model.

Radiodynamic Therapy Using Local Administration of 5-Aminolevulinic Acid for In Vivo Osteosarcoma Xenograft Model.

Journal: In vivo (Athens, Greece)

Published: May 15, 2026

Regorafenib in Pediatric Patients With Advanced Osteosarcoma: A Case Series from a Single Institution.

Regorafenib in Pediatric Patients With Advanced Osteosarcoma: A Case Series from a Single Institution.

Journal: Anticancer research

Published: May 10, 2026

Clinical Outcome in Elderly Patients (Aged ≥ 65 Years) Treated with Chemotherapy for Advanced Soft Tissue Sarcomas: A Tokai Musculoskeletal Oncology Consortium Study.

Clinical Outcome in Elderly Patients (Aged ≥ 65 Years) Treated with Chemotherapy for Advanced Soft Tissue Sarcomas: A Tokai Musculoskeletal Oncology Consortium Study.

Journal: Cancers

Published: April 23, 2026

Radiodynamic Therapy Using 5-Aminolevulinic Acid as a New Treatment Option for Osteosarcoma: An In Vitro and In Vivo Study.

Radiodynamic Therapy Using 5-Aminolevulinic Acid as a New Treatment Option for Osteosarcoma: An In Vitro and In Vivo Study.

Journal: Anticancer research

Published: March 31, 2026

Amlodipine Suppresses Lung Metastasis by Increasing Cell Stiffness.

Amlodipine Suppresses Lung Metastasis by Increasing Cell Stiffness.

Journal: Anticancer research

Published: November 14, 2025

Long-term clinical outcome of lung radiofrequency ablation in patients with musculoskeletal sarcoma.

Long-term clinical outcome of lung radiofrequency ablation in patients with musculoskeletal sarcoma.

Journal: International journal of clinical oncology

Published: September 10, 2025

Preoperative administration of denosumab is a feasible adjuvant option for the treatment of resectable giant cell tumor of bone in the spine: A multi-institutional study by the Japanese Musculoskeletal Oncology group.

Preoperative administration of denosumab is a feasible adjuvant option for the treatment of resectable giant cell tumor of bone in the spine: A multi-institutional study by the Japanese Musculoskeletal Oncology group.

Journal: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association

Published: August 06, 2025

Clinical outcome of patients with soft tissue sarcoma after bone metastases: Tokai musculoskeletal oncology consortium study.

Clinical outcome of patients with soft tissue sarcoma after bone metastases: Tokai musculoskeletal oncology consortium study.

Journal: Japanese journal of clinical oncology

Published: May 08, 2025

MASP1 as a favorable prognostic biomarker in pediatric osteosarcoma: an integrated analysis of machine learning, bioinformatics, and validation experiments.

MASP1 as a favorable prognostic biomarker in pediatric osteosarcoma: an integrated analysis of machine learning, bioinformatics, and validation experiments.

Journal: Translational pediatrics

Published: April 17, 2025

Unplanned Excision in Soft Tissue Sarcoma: Current Knowledge and Remaining Gaps.

Unplanned Excision in Soft Tissue Sarcoma: Current Knowledge and Remaining Gaps.

Journal: Diagnostics (Basel, Switzerland)

Published: December 27, 2024

Showing 1-12 of 152

Last Updated: 09/26/2026